Nonsteroidal Anti-Inflammatory Drugs

作者: Leslie J. Crofford

DOI: 10.1007/978-0-387-68566-3_41

关键词:

摘要: Pain (dolor), swelling (tumor), erythema (rubor), and warmth (calor), the cardinal features of inflammation, are present in most patients with rheumatic diseases. Therapeutic strategies to reduce inflammation have been used for centuries, beginning botanical treatments both Western Eastern medical traditions (1). The first isolated plant constituent be tested as an anti-inflammatory drug was salicylic acid from willow bark, which chemically altered acetyl improve its pharmacologic properties. Acetyl became “aspirin” 1899, one drugs widely marketed, aspirin remains today. Other that share anti-inflammatory, analgesic, antipyretic properties termed nonsteroidal (NSAIDs), a diverse group compounds (Table 41-1). It established 1971 salicylates other NSAIDs act by blocking synthesis prostaglandins (PGs), products metabolism membrane-associated fatty arachidonic acid. This finding demonstrated conclusively PGs play important role mediating symptoms signs inflammation. However, normal physiology well disease. As consequence, all possess predictable therapeutic adverse effects must understood order use these safely.

参考文章(44)
Brash Ar, Lawson Ja, Maas Rl, FitzGerald Ga, Oates Ja, Roberts Lj, Aspirin inhibits endogenous prostacyclin and thromboxane biosynthesis in man. Advances in prostaglandin, thromboxane, and leukotriene research. ,vol. 11, pp. 265- 266 ,(1983)
K M Harper, T L Hunt, G S Geis, A Karim, D S Tolbert, R C Hubbard, Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis. The Journal of Rheumatology. ,vol. 26, pp. 2539- 2543 ,(1999)
P.E. Lipsky, S.B. Abramson, R.N. Dubois, L.S. Simon, L.B.A. van de Putte, L.J. Crofford, The classification of cyclooxygenase inhibitors. The Journal of Rheumatology. ,vol. 25, pp. 2298- 2303 ,(1998)
Hiroyuki Toh, Atsushi Ichikawa, Shuh Narumiya, Molecular evolution of receptors for eicosanoids FEBS Letters. ,vol. 361, pp. 17- 21 ,(1995) , 10.1016/0014-5793(95)00129-W
Luis Alberto García Rodríguez, Sonia Hernández-Díaz, Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology. ,vol. 12, pp. 570- 576 ,(2001) , 10.1097/00001648-200109000-00018
M. Michael Wolfe, David R. Lichtenstein, Gurkirpal Singh, Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. The New England Journal of Medicine. ,vol. 340, pp. 1888- 1899 ,(1999) , 10.1056/NEJM199906173402407
Irmgard Tegeder, Josef Pfeilschifter, Gerd Geisslinger, Cyclooxygenase-independent actions of cyclooxygenase inhibitors The FASEB Journal. ,vol. 15, pp. 2057- 2072 ,(2001) , 10.1096/FJ.01-0390REV
Garret A. FitzGerald, Carlo Patrono, The coxibs, selective inhibitors of cyclooxygenase-2. The New England Journal of Medicine. ,vol. 345, pp. 433- 442 ,(2001) , 10.1056/NEJM200108093450607